IMMUNIC, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

IMMUNIC, INC. reported Cash And Cash Equivalents At Carrying Value of $15.48 million for the year ending 2025.

  • IMMUNIC, INC. showed a decrease of -56.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), IMMUNIC, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 1,828.1%.
  • Historical annual values: Fiscal year 2025: $15.48 million | Fiscal year 2024: $35.67 million | Fiscal year 2023: $46.67 million | Fiscal year 2022: $106.75 million | Fiscal year 2021: $86.86 million | Fiscal year 2020: $127.45 million | Fiscal year 2019: $29.37 million | Fiscal year 2018: $13.07 million | Fiscal year 2017: $56.90 million | Fiscal year 2016: $59.99 million | Fiscal year 2015: $83.42 million | Fiscal year 2014: $102.24 million | Fiscal year 2013: $38.19 million | Fiscal year 2012: $4.48 million | Fiscal year 2011: $803.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: